Originally published February 23 2006
Drug industry plans to increase flu vaccine production for upcoming year
by Mike Adams, the Health Ranger, NaturalNews Editor
Andrew MacKnight, executive director of vaccine supply for GlaxoSmithKline, discusses the drug industry's plans to increase production of flu vaccine from 95 to 120 million doses over the coming year.
Expecting rising demand for flu shots, pharmaceutical companies are gearing up to produce as many as 120 million doses of vaccine for next flu season.
That far surpasses the record of 95 million doses produced in 2002.
Vaccine makers say their expectation seems warranted for a number of reasons, including public fears of bird flu, better government reimbursement for shots and indications that federal health officials may one day recommend flu shots for nearly everyone.
"We and other manufacturers are making the investments to ensure that there will be sustainable supplies going forward," said Andrew MacKnight, executive director of vaccine supply for GlaxoSmithKline, speaking at a flu vaccine summit meeting in Atlanta on Tuesday.
The manufacturers' projections could mean an end to the shortages that have worried patients and health care workers for the past three autumns.
The company recently acquired plants in Canada and Pennsylvania and is expanding its plants in Dresden, Germany.
Sanofi Pasteur, the main vaccine producer for the 2005-06 season, broke ground last July on a vaccine plant in Swiftwater, Pa., to double the company's capacity.
The predictions were made at a two-day meeting in Atlanta to discuss the vaccine supply.
It was co-hosted by the CDC and the American Medical Association.
Between 5 percent and 20 percent of the U.S. population gets the flu each year, according to the AMA.
The illness leads to about 36,000 deaths and 200,000 hospitalizations each year, according to federal officials.
The CDC recommends flu vaccinations for groups most at risk of complications, including the elderly and people with weakened immune systems.
About 86 million doses of vaccine were produced for the current season in the United States, up from about 61 million in the 2004-05 flu season, according to the CDC.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml